Results 71 to 80 of about 412,436 (221)
Re-evaluation of hematocrit as a determinant of thrombotic risk in erythrocytosis
Here we critically evaluate the role of elevated hematocrit as the principal determinant of thrombotic risk in polycythemia and erythrocytosis, defined by an expansion of red cell mass.
Victor R. Gordeuk +2 more
doaj +1 more source
ABSTRACT Objective To evaluate the association between admission hemoglobin levels and in‐hospital functional outcomes in patients with acute hemorrhagic stroke in Pakistan. Background Abnormal hemoglobin levels have an impact on cerebral perfusion and oxygen delivery to the brain, potentially affecting the recovery in stroke patients.
Ayesha Johar +10 more
wiley +1 more source
POLYCYTHEMIA VERA: PRESENTATION AND MANAGEMENT
: Background: Polycythemia vera (PV), alongside primary myelofibrosis (MF) and essential thrombocythemia (ET), is a classic Philadelphia chromosome-negative myeloproliferative neoplasm (MPN) characterized primarily by an expanded red platelet mass ...
Omar Hasan Badahman, Hassan Abdulwahab Almumen, Ali Abdulaziz Alshamrani, Esraa Ebraheem Kamal, Alaa Jamal Akbar, Shaima Mohammed Alghuraybi, Eidan Bakheet Almalki, Abdulsalam Jawwad Al Hassan, Zainab Hassan Albahrani, Asmaa Abdullah Alzahrani
core +1 more source
Polycythemia Vera: New Diagnostic Concept and Its Types
Polycythemia vera (PV) is a clonal Ph-negative myeloproliferative disorder characterized by excessive myeloid proliferation of three hematopoietic cell lineages leading to ineffective myelopoiesis.
Alla Mikhailovna Kovrigina, V. V. Baikov
doaj +1 more source
ABSTRACT An 82‐year‐old woman with JAK2‐mutated myelofibrosis who developed hemoptysis after initiation of ruxolitinib. She presented with anemia and ground‐glass opacities and was treated with antibiotics. She was readmitted with worsening respiratory symptoms. Sputum cultures yielded Mycobacterium avium.
Mataichi Sekiya +3 more
wiley +1 more source
An image from a peripheral blood smear showing a thick smear with an abundant amount of red blood cells and platelets often seen in patients with polycythemia vera (50X oil immersion). A neutrophil is also present (center)
To, Michelle, Kwon, Gloria
core +1 more source
The molecular pathogenesis of myeloproliferative neoplasms
Myeloproliferative neoplasms (MPNs) are a heterogeneous group of haematological stem cellmalignancies characterised by proliferation of one or more cells of the myeloid lineage.
Jones, Amy Victoria
core +1 more source
Ruxolitinib pharmacokinetics (PK) has been characterized in clinical trials but remains poorly documented in real‐world practice. This project aimed to investigate ruxolitinib PK in routine clinical practice, identify factors driving its variability, and explore exposure–response relationships to assess the potential role of therapeutic drug monitoring.
Jérémie Tachet +11 more
wiley +1 more source
The role of the environment in the origin of polycythemia vera has not been well documented. Recently, molecular diagnostic tools have been developed to facilitate the diagnosis of polycythemia vera.
Hoffman, Ronald +7 more
core +2 more sources
What's Your Diagnosis? A Case of Extreme Thrombocytosis in a Dog
Veterinary Clinical Pathology, EarlyView.
Stephanie F. Anderson +5 more
wiley +1 more source

